“…Low ASPECTS [50] Large infarct volume [51] Insufficient arterial collateral status [52] The delayed PTV [34] Leukoaraiosis [26] Brain atrophy [53] Encephaledema assessed by NWU [54,55] CT selection for MT as compared to MRI [16] NCCT±CTA selection for EVT-eligible patients as compared to NCCT with CT perfusion imaging±CTA [33] Laboratory data High serum glucose [48] High blood NLR [56] Admission systemic inflammatory response index (SIRI) calculated as ANC × AMC/ALC ≥3.8 × 10 9 /L [24] High baseline serum CysC [29] High level of MMP-9, tenascin-C, and thioredoxin [25] Decreased level of post-EVT lipid mediators LXA4 and LXA4/LTB4 ratio [57] Decreased level of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) and gelsolin [25] FR, futile reperfusion; EVT, endovascular treatment; NIHSS, National Institutes of Health Stroke Scale; eTICI, expanded thrombolysis in cerebral infarction; ASPECTS, Alberta Stroke Program Early Computed Tomography Score; CT, computed tomography; MT, mechanical thrombectomy; MRI, magnetic resonance imaging; NCCT, noncontrast computed tomography; CTA, computed tomography angiographt; GA, general anesthesia; DTR, doorto-angiographic reperfusion; sICH; symptomatic intracranial hemorrhage; PTV, peak time of venous outflow; NW, net water uptake; NLR neutrophil to lymphocyte ratio; CysC, cystatin C; MMP-9, matrix metalloproteinase-9; ANC, absolute neutrophil count; AMC, absolute monocyte count; ALC, absolute lymphocyte count; LXA4, lipoxin A4; LTB4, leukotriene B4. DOI: 10.1159/000528922 real world is particularly subjected to paucity.…”